Latest News for: bcg

Edit

BCG Appoints Managing Directors, Partners in Lagos

This Day 23 Jan 2026
Boston Consulting Group (BCG) has announced the appointment of Olayinka Majekodunmi and Phillipa Osakwe-Okoye as Managing Directors and Partners in its Nigeria office, effective 01 January 2026.
Edit

Tokenized assets could hit $11T says Cathie Wood’s Ark Invest

Cryptopolitan 22 Jan 2026
Ark Invest predicts tokenized assets will expand to $11 trillion by 2030, according to its “Big Ideas 2026” report ... Source ... The Boston Consulting Group (BCG) and Ripple report predicts tokenized assets may reach nearly $19 trillion by 2033.
Edit

Are you a consultant? Tell us how you're using AI.

Business Insider 21 Jan 2026
Now, artificial intelligence is quietly rewriting that playbook ... BCG has leaned into building thousands of custom GPTs for internal and client use and evaluating how its employees use them ... Answer our survey below ... ....
Edit

ImmunityBio Advances Regulatory Discussions with FDA on Potential Resubmission Path for ANKTIVA® in BCG-Unresponsive Papillary ...

Business Wire 20 Jan 2026
... (BCG) in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with papillary tumors.
Edit

ImmunityBio Advances Regulatory Discussions with FDA on Potential Resubmission Path for ANKTIVA® in BCG-Unresponsive Papillary Bladder Cancer

Pharmiweb 20 Jan 2026
FDA regarding the Company’s supplemental Biologics License Application (sBLA) for ANKTIVA® (nogapendekin alfa inbakicept) plus Bacillus Calmette-Guérin (BCG) in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with papillary tumors.
Edit

World Economic Forum: Indian businesses must be competitive on cost, scale and resilience, says BCG

The Economic Times 18 Jan 2026
.
Edit

ImmunityBio Advances First-Line BCG Naive NMIBC Program with Enrollment Exceeding Expectations and Positive Interim Analysis ...

Business Wire 16 Jan 2026
... registrational trial in BCG-na�ve non-muscle-invasive bladder cancer (NMIBC), QUILT-2.005.
Edit

ImmunityBio Advances First-Line BCG Naive NMIBC Program with Enrollment Exceeding Expectations and Positive Interim Analysis for ANKTIVA® Plus BCG

Pharmiweb 16 Jan 2026
Enrollment of BCG ... The interim analysis demonstrated that ANKTIVA significantly prolonged the duration of complete response when combined with BCG compared to BCG alone in the BCG-naïve NMIBC setting.
Edit

New BCG report shows companies plan to double their spending on AI in 2026

China Daily 16 Jan 2026
"Despite economic uncertainty, this anticipated surge in spending reflects how much of a priority AI has become in the business world," Christoph Schweizer, BCG's CEO and coauthor of the report, said ...
×
×
×
×